Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Intellectual property rights in publicly funded biobanks: much ado about nothing?

Nature Biotechnology volume 29, pages 319–323 (2011)Cite this article

Subjects

Should biobanks be involved in downstream intellectual property rights developed from accessing materials contained in them, and to what extent?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IPRs developed in the context of biobanks.
Figure 2: Innovation cycle in publicly funded biobanks.

References

  1. O'Rahilly, S. & Wareham, N.J. N. Engl. J. Med. 355, 306–308 (2006).

    Article  CAS  Google Scholar 

  2. Plomin, R., Haworth, C.M. & Davis, O.S. Nat. Rev. Genet. 10, 872–878 (2009).

    Article  CAS  Google Scholar 

  3. Burton, P.R. et al. Int. J. Epidemiol. 38, 263–273 (2009).

    Article  Google Scholar 

  4. Fortier, I. et al. Intl. J. Epidemiol. 39, 1383–1393 (2010).

    Article  Google Scholar 

  5. Davis, R.L. & Khoury, M.J. Community Genet. 10, 181–185 (2007).

    PubMed  Google Scholar 

  6. Knoppers, B.M. et al. Eur. J. Hum. Genet. 16, 664–665 (2008).

    Article  CAS  Google Scholar 

  7. Burton, P., Fortier, I. & Knoppers, B.M. in Human Genome Epidemiology: Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease 704 (Oxford University Press, 2009).

    Google Scholar 

  8. Laurent, P. & Vilches Armesto, L. Cahiers Droit, Sciences & Technologies 3, 193–214 (2009).

    Google Scholar 

  9. P 3 G Observatory. Study Catalogue http://www.p3gobservatory.org/studylist.htm

  10. Godard, B., Marshall, J. & Laberge, C. Community Genet. 10, 147–158 (2007).

    PubMed  Google Scholar 

  11. Council of Europe. Recommendation of the Committee of Ministers to Member States on Research on Biological Materials of Human Origin. p. 8 (Strasbourg: 2006).

  12. International Expert Group on Biotechnology, Innovation and Intellectual Property: Montreal. Toward a New Era of Intellectual Property: From Confrontation to Negotiation (September 2008). http://www.theinnovationpartnership.org/data/ieg/documents/report/TIP_Report_E.pdf

  13. Sen, D. & Tauman, Y. Games Econ. Behav. 59, 163–186 (2007).

    Article  Google Scholar 

  14. Directive on the legal protection of databases. in Directive 96/9/ EC, E.P. Council, Editor (11 March 1996).

  15. Howell, R.G. et al. in Intellectual Property Law: Cases and Materials 1057 (Emond Montgomery Publications, Toronto, 1999)

    Google Scholar 

  16. Bovenberg, J.A. Nat. Biotechnol. 18, 907 (2000).

    Article  CAS  Google Scholar 

  17. Wu, X. Berkeley Technol. Law J. 17, 571 (2002).

    Google Scholar 

  18. Freedman, C.D. Fordham Intell. Prop. Media & Ent. L.J. 13, 35 (2002).

  19. Martino, P. Geo. J.L. & Pub. Pol'y. 4, 557 (2006).

    Google Scholar 

  20. Pachnanda, A. Buffalo Law Rev. 51, 219–250 (2003).

    Google Scholar 

  21. Feist publ'ns Inc. v. Rural Tel Serv. Co. 1991. p. 340.

  22. Statistics Canada (Science, Innovation and Electronic Information Division). Survey of Intellectual Property Commercialization in the Higher Education Sector (2006/2005) (Statistics Canada, 2008).

  23. Statistics Canada (Science, Innovation and Electronic Information Division). Survey of Intellectual Property Commercialization in the Higher Education Sector (2007). (Statistics Canada, 2009).

  24. Gold, E.R. et al. PLoS Med. 7, e1000208 (2010).

    Article  Google Scholar 

  25. Cook-Deegan, R., Chandrasekharan, S. & Angrist, M. Nature 458, 405–406 (2009).

    Article  CAS  Google Scholar 

  26. Dent, C. et al. (eds.). in Research Use of Patented Knowledge: A Review (OECD Publications, Paris, 2006). http://www.oecd.org/dataoecd/15/16/36311146.pdf

    Google Scholar 

  27. Reichman, J.H. in Non-Voluntary Licensing of Patented Inventions (UNCTAD, Geneva, 2003).

    Book  Google Scholar 

  28. Correa, C. Intergrating Public Health Concerns Into Patent Legislation in Developing Countries (South Centre, Geneva, 2000).

  29. Association for Molecular Pathology et al. v. U.S. Patent and Trademark Office et al. in 1:09-cv-04515. 2010, New York Southern District Court.

  30. Caulfield, T., Bubela, T. & Murdoch, C.J. Genet. Med. 9, 850–855 (2007).

    Article  Google Scholar 

  31. National Institutes of Health. Best Practices for the Licensing of Genomic Inventions (NIH, Washington, DC; 2005). http://www.ott.nih.gov/pdfs/70FR18413.pdf

  32. Organisation for Economic Co-Operation and Development. Guidelines for the Licensing of Genetic Inventions (OECD, Paris, 2006). http://www.oecd.org/dataoecd/39/38/36198812.pdf

  33. Nielson, J. Federal L. Rev. 33, 169 (2004).

    Article  Google Scholar 

  34. Merck & Co. v. Apotex Inc., in R.C.F. 2007. p. 588.

  35. Micro Chemicals Ltd. v. Smith Kline & French Inter-American Corp. in R.C.S. 1972. p. 506.

  36. Smith Kline & French Laboratories Ltd v. Attorney-General (NZ) in NZLR. 1991. p. 560.

  37. Frearson v. Loe. in ChD. 1876. p. 48.

  38. Madey v. Duke. in USPQ2d. 2002, Fed. Cir. p. 1737.

Download references

Acknowledgements

The authors wish to acknowledge the support of the Public Population Project in Genomics (P3G) (which is hosted by the University of Montreal and financially supported by Genome Canada and Genome Quebec).

Author information

Authors and Affiliations

  1. Saminda Pathmasiri and Myléne Deschênes are at the Public Population Project in Genomics (P3G) Consortium, Montreal, Quebec, Canada,

    Saminda Pathmasiri & Mylène Deschênes

  2. Yann Joly, Tara Mrejen and Bartha Maria Knoppers are at McGill University, Montreal, Quebec, Canada,

    Yann Joly & Tara Mrejen

  3. Francis Hemmings is at the University of Montreal, Montreal, Quebec, Canada.,

    Francis Hemmings & Bartha Maria Knoppers

Authors
  1. Saminda Pathmasiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mylène Deschênes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yann Joly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tara Mrejen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francis Hemmings
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bartha Maria Knoppers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saminda Pathmasiri.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pathmasiri, S., Deschênes, M., Joly, Y. et al. Intellectual property rights in publicly funded biobanks: much ado about nothing?. Nat Biotechnol 29, 319–323 (2011). https://doi.org/10.1038/nbt.1834

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1834

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing